A computer modeling method to analyze rideshare data for the surveillance of novel strains of SARS-CoV-2.
COVID-19
Computer simulation
Epidemiological monitoring
Epidemiology
Proof of concept study
SARS-CoV-2
Journal
Annals of epidemiology
ISSN: 1873-2585
Titre abrégé: Ann Epidemiol
Pays: United States
ID NLM: 9100013
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
05
12
2021
revised:
15
07
2022
accepted:
29
08
2022
pubmed:
11
9
2022
medline:
29
11
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
No method is available to systematically study SARS-CoV-2 transmission dynamics using the data that rideshare companies share with government agencies. We developed a proof-of-concept method for the analysis of SARS-CoV-2 transmissions between rideshare passengers and drivers. To assess whether this method could enable hypothesis testing about SARS-CoV-2, we repeated ten 200-day agent-based simulations of SARS-CoV-2 propagation within the Los Angeles County rideshare network. Assuming data access for 25% of infections, we estimated an epidemiologist's ability to analyze the observable infection patterns to correctly identify a baseline viral variant A, as opposed to viral variant A with mask use (50% reduction in viral particle exchange), or a more infectious viral variant B (300% higher cumulative viral load). Simulations had an average of 190,387 potentially infectious rideshare interactions, resulting in 409 average diagnosed infections. Comparison of the number of observed and expected passenger-to-driver infections under each hypothesis demonstrated our method's ability to consistently discern large infectivity differences (viral variant A vs. viral variant B) given partial data from one large city, and to discern smaller infectivity differences (viral variant A vs. viral variant A with masks) given partial data aggregated across multiple cities. This novel statistical method suggests that, for the present and subsequent pandemics, government-facilitated analysis of rideshare data combined with diagnosis records may augment efforts to better understand viral transmission dynamics and to measure changes in infectivity associated with nonpharmaceutical interventions and emergent viral strains.
Identifiants
pubmed: 36087658
pii: S1047-2797(22)00219-8
doi: 10.1016/j.annepidem.2022.08.051
pmc: PMC9452418
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
136-142Informations de copyright
Copyright © 2022. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Nat Commun. 2020 Sep 30;11(1):4961
pubmed: 32999287
Lancet. 2020 Sep 5;396(10252):e24
pubmed: 32861312
Cureus. 2021 Feb 1;13(2):e13064
pubmed: 33680606
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
N Engl J Med. 2020 Aug 20;383(8):779-786
pubmed: 32558484
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33277325
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Science. 2021 Sep 17;373(6561):1372-1377
pubmed: 34385356
N Engl J Med. 2021 Aug 19;385(8):759-760
pubmed: 34161702
Science. 2020 May 29;368(6494):951-954
pubmed: 32393527
N Engl J Med. 2020 Dec 17;383(25):2407-2416
pubmed: 33176093
Nat Med. 2020 Aug;26(8):1183-1192
pubmed: 32770165
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Nat Med. 2020 Nov;26(11):1714-1719
pubmed: 32943787
Health Syst (Basingstoke). 2021 Jan 17;10(1):31-40
pubmed: 33763227
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Clin Infect Dis. 2021 Feb 16;72(4):604-610
pubmed: 32726405
Euro Surveill. 2022 Mar;27(10):
pubmed: 35272744
MMWR Morb Mortal Wkly Rep. 2021 Aug 06;70(31):1059-1062
pubmed: 34351882
JAMA. 2020 Aug 18;324(7):703-704
pubmed: 32663246
Nature. 2005 Sep 8;437(7056):209-14
pubmed: 16079797
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290
pubmed: 34529637
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176
pubmed: 34437525
BMC Public Health. 2014 Dec 29;14:1328
pubmed: 25547377
Clin Infect Dis. 2022 Jan 29;74(2):339-342
pubmed: 33893474